XML 42 R30.htm IDEA: XBRL DOCUMENT v3.20.1
Derivative Financial Instruments (Tables)
3 Months Ended
Mar. 29, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Summary of Cash Flow Hedging Instruments
At March 29, 2020, March 31, 2019 and December 29, 2019, the notional amounts and fair values of the Company's foreign currency forward contracts designated as cash flow hedging instruments were as follows:
 
March 29, 2020
 
March 31, 2019
 
December 29, 2019
Hedged transaction
Notional
Amount
 
Fair
Value
 
Notional
Amount
 
Fair
Value
 
Notional
Amount
 
Fair
Value
Inventory purchases
$
343,227

 
32,186

 
486,999

 
21,649

 
398,800

 
8,727

Sales
101,120

 
4,761

 
263,221

 
8,358

 
124,920

 
4,037

Production financing and other
161,303

 
6,687

 
26,422

 
190

 
19,499

 
140

Total
$
605,650

 
43,634

 
776,642

 
30,197

 
543,219

 
12,904



Schedule of Foreign Currency Forward Contracts Designated as Cash Flow Hedges The fair values of the Company's foreign currency forward contracts designated as cash flow hedges are recorded in the consolidated balance sheets at March 29, 2020, March 31, 2019 and December 29, 2019 as follows:
 
March 29,
2020
 
March 31,
2019
 
December 29,
2019
Prepaid expenses and other current assets
 
 
 
 
 
Unrealized gains
$
40,376

 
22,737

 
12,133

Unrealized losses
(1,893
)
 
(2,008
)
 
(3,955
)
Net unrealized gains
$
38,483

 
20,729

 
8,178

 
 
 
 
 
 
Other assets
 
 
 
 
 
Unrealized gains
$
7,128

 
9,752

 
6,652

Unrealized losses

 
(239
)
 

Net unrealized gains
$
7,128

 
9,513

 
6,652

 
 
 
 
 
 
Accrued liabilities
 
 
 
 
 
Unrealized gains
$

 

 
293

Unrealized losses
(1,974
)
 
(45
)
 
(2,219
)
Net unrealized losses
$
(1,974
)
 
(45
)
 
(1,926
)
 
 
 
 
 
 
Other liabilities
 
 
 
 
 
Unrealized gains
$

 

 

Unrealized losses
(3
)
 

 

Net unrealized losses
$
(3
)
 

 


Schedule of Net Gains (Losses) on Cash Flow Hedges Activities
Net gains (losses) on cash flow hedging activities have been reclassified from other comprehensive earnings (loss) to net earnings for the quarters ended March 29, 2020 and March 31, 2019 as follows:
 
Quarter Ended
 
March 29,
2020
 
March 31,
2019
Statements of Operations Classification
 
 
 
Cost of sales
$
3,957

 
2,614

Net revenues
343

 
878

Other
81

 
118

Net realized gains
$
4,381

 
3,610


Fair Values of Undesignated Derivative Financial Instruments
At March 29, 2020, March 31, 2019 and December 29, 2019, the fair values of the Company's undesignated derivative financial instruments were recorded in the consolidated balance sheets as follows:
 
March 29,
2020
 
March 31,
2019
 
December 29,
2019
Prepaid expenses and other current assets
 
 
 
 
 
Unrealized gains
$
1,170

 
2,391

 

Unrealized losses

 
(337
)
 

Net unrealized gains
$
1,170

 
2,054

 

 
 
 
 
 
 
Accrued liabilities
 
 
 
 
 
Unrealized gains
$
1,252

 

 
13

Unrealized losses
(12,406
)
 

 
(3,820
)
Net unrealized losses
$
(11,154
)
 

 
(3,807
)
 
 
 
 
 
 
Total unrealized (losses) gains, net
$
(9,984
)
 
2,054

 
(3,807
)